Project Details
| Status | Active |
|---|---|
| Effective start/end date | 7/5/18 → 7/5/24 |
Funding
- Oncolytics Biotech Inc. (Prot #NU 18I01)
Prot #NU 18I01: A Phase 2 study of pembrolizumab in combination with pelareorep in patients with advanced pancreatic adenocarcinoma
- Mahalingam, Devalingam (PD/PI)
Project: Research project